Ostatní
Návod 
Aclaris Therapeutics, Inc.
ACRS
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.2B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-118%
ROA
-81%
PE
-7
PS
58
Cena 1R
1-3
⌀ Cena
1.93
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda
Profil
Aclaris Therapeutics, Inc. provozuje klinickou biofarmaceutickou společnost, vyvíjí nové lékové kandidáty na imunitně-zánětlivé choroby ve Spojených státech. Působí ve dvou segmentech: terapeutický a smluvní výzkum. Segment Therapeutics se zabývá identifikací a vývojem inovačních terapií, které řeší významné nenaplněné potřeby v oblasti imunitně-zánětlivých onemocnění. Segment Smluvní výzkum se zabývá poskytováním laboratorních služeb. Společnost také vyvíjí Zunsemetinib, inhibitor MK2 pro léčbu středně těžké až těžké revmatoidní a psoriatické artritidy a Hidradenitis supurativa, a ATI- 1777, měkký inhibitor JAK 1/3 pro léčbu středně těžké až těžké atopické dermatitidy. Kromě toho se vyvíjí ATI-2138, inhibitor ITK/TXK/JAK3 jako potenciální léčba autoimunitních onemocnění zprostředkovaných T buňkami; program zkreslení střev pro zánětlivé onemocnění střev; a ATI-2231, léčba inhibitorem MK2 pro pankreatický a metastazující karcinom prsu. Společnost byla založena v roce 2012 a sídlí v Wayne v Pensylvánii.
Sektor
Healthcare
Odvětví
Medical - Diagnostics & Research
Počet zaměstnanců
61
Založení
2015-10-06
Podobné společnosti
$ 2.37
- $ 0.19
$ 2.48
+ $ 0.01
$ 10.31
+ $ 0.23
$ 3.05
- $ 0.14
$ 6.50
+ $ 0.49
$ 1.19
+ $ 0.01
$ 6.33
- $ 1.05
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 7.8 | 7.8 | 18.7 | 31.2 | 29.8 | 6.8 | 6.5 | 4.2 | 10.1 | 1.7 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cost of Revenues | 2.1 | 2.1 | 2.8 | 18.1 | 12.0 | 4.7 | 5.1 | 4.1 | 6.9 | 1.2 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 5.7 | 5.7 | 15.9 | 13.2 | 17.8 | 2.0 | 1.3 | 0.2 | 3.2 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 1.3 | 3.3 | 1.8 | 1.5 | 9.2 | 4.3 | 2.8 | 2.4 | 17.6 | 9.3 | |
| Cost of Revenues | -0.8 | 0.5 | 1.9 | 0.5 | 9.3 | 2.4 | 1.9 | 1.8 | 6.4 | 0.8 | |
| Gross Profit | 2.1 | 2.8 | -0.1 | 0.9 | -0.1 | 1.9 | 0.9 | 0.6 | 11.1 | 8.4 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 98.4 | 77.8 | 43.8 | 31.7 | 64.9 | 63.0 | 39.8 | 33.5 | 15.3 | 6.5 | 3.5 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 31.1 | 25.1 | 23.6 | 20.5 | 27.8 | 75.6 | 33.1 | 15.1 | 5.3 | 2.0 | 1.8 | |
| Depreciation & Amortization | 0.6 | 0.5 | 0.8 | 0.9 | 5.5 | 24.3 | 1.3 | 37.0 | 1.9 | 0.4 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Total Operating Expenses | 82.1 | 82.1 | 157.9 | 130.8 | 102.9 | 67.4 | 52.3 | 92.7 | 138.7 | 72.9 | 48.6 | 20.7 | 8.5 | 5.3 | |
| Operating Income | -76.4 | -76.4 | -141.9 | -97.4 | -85.2 | -65.4 | -50.9 | -111.1 | -135.4 | -72.4 | -48.6 | -20.7 | -8.5 | -5.3 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 26.6 | 23.9 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.2 | 7.1 | ||
| Depreciation & Amortization | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.0 | 0.2 | 0.2 | 0.2 | ||
| Total Operating Expenses | 24.8 | 19.9 | 18.3 | 19.0 | 99.6 | 12.4 | 13.7 | 19.5 | 34.9 | 40.0 | ||
| Operating Income | -22.7 | -17.1 | -18.4 | -18.1 | -99.7 | -10.5 | -12.9 | -18.9 | -4.0 | -31.6 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 7.6 | 7.6 | 8.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 4.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | 11.5 | 11.5 | 9.9 | 8.5 | -1.8 | -25.5 | -0.4 | -2.5 | 2.7 | 2.1 | 0.5 | 0.1 | 0.0 | 0.0 | |
| IBT | -64.9 | -64.9 | -132.1 | -88.8 | -86.9 | -90.9 | -51.3 | -113.5 | -132.7 | -70.4 | -48.1 | -20.6 | -8.5 | -5.2 | |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | -0.4 | 1.8 | 23.4 | -0.2 | 29.3 | 2.7 | -1.8 | -0.1 | -0.1 | 0.0 | 0.0 | |
| Net Income | -64.9 | -64.9 | -132.1 | -88.5 | -88.7 | -114.3 | -51.2 | -142.9 | -132.7 | -68.5 | -48.1 | -20.6 | -8.5 | -5.2 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 1.6 | 1.8 | 2.0 | 2.2 | 2.1 | 2.0 | 1.9 | 2.0 | 0.0 | 2.3 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Other Expense | 2.9 | 2.5 | 3.0 | 3.0 | 3.1 | 2.9 | 1.9 | 2.0 | 2.2 | 2.3 | ||
| IBT | -19.8 | -14.6 | -15.4 | -15.1 | -96.6 | -7.6 | -11.0 | -16.9 | -1.9 | -29.3 | ||
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.4 | -0.2 | ||
| Net Income | -19.8 | -14.6 | -15.4 | -15.1 | -96.6 | -7.6 | -11.0 | -16.9 | -1.5 | -29.3 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-1.27 | $-1.36 | $-2.01 | $-1.20 | $-3.46 | $-4.03 | $-2.44 | $-2.25 | $-3.37 | $-0.80 | $-0.49 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-1.27 | $-1.36 | $-2.01 | $-1.20 | $-3.46 | $-4.03 | $-2.44 | $-2.25 | $-3.37 | $-0.80 | $-0.49 | |
| Shares Outstanding | 122.7 | 122.7 | 77.3 | 69.8 | 65.2 | 56.7 | 42.5 | 41.3 | 32.9 | 28.1 | 21.4 | 6.1 | 10.7 | 10.7 | |
| Diluted Shares Outstanding | 122.7 | 122.7 | 77.3 | 69.8 | 65.2 | 56.7 | 42.5 | 41.3 | 32.9 | 28.1 | 21.4 | 6.1 | 10.7 | 10.7 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.02 | $-0.41 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.02 | $-0.41 | ||
| Shares Outstanding | 122.7 | 122.6 | 122.6 | 122.4 | 95.3 | 71.4 | 71.3 | 71.1 | 70.9 | 70.8 | ||
| Diluted Shares Outstanding | 122.7 | 122.6 | 122.6 | 122.4 | 95.3 | 71.4 | 71.3 | 71.1 | 70.9 | 70.8 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 22.8 | 24.6 | 39.9 | 45.3 | 27.3 | 54.1 | 35.9 | 57.0 | 208.9 | 30.2 | 9.9 | 10.8 | 9.6 | |
| Short Term Investments | 88.3 | 89.0 | 79.2 | 172.3 | 164.1 | 32.1 | 39.1 | 111.0 | 173.7 | 107.1 | 75.0 | 5.4 | 3.7 | |
| Total Cash & ST Investments | 111.1 | 113.6 | 119.1 | 229.8 | 225.7 | 54.1 | 75.0 | 168.0 | 208.9 | 174.1 | 92.0 | 16.1 | 13.3 | |
| Accounts Receivable | 0.3 | 0.3 | 0.3 | 0.5 | 0.6 | 0.8 | 0.7 | 4.9 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Inventory | 0.0 | 0.0 | 0.0 | -12.2 | -34.2 | 0.0 | 5.0 | 0.8 | -6.4 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 6.2 | 12.0 | 9.5 | 13.5 | 13.0 | 2.6 | 3.1 | 5.9 | 5.9 | 1.3 | 1.7 | 0.2 | 0.1 | |
| Total Current Assets | 117.6 | 126.0 | 128.9 | 231.6 | 205.0 | 57.5 | 83.8 | 179.5 | 208.9 | 174.1 | 92.0 | 16.3 | 13.4 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 25.3 | 25.4 | 30.4 | 24.6 | 47.7 | 22.8 | 35.8 | 39.9 | 39.0 | 31.2 | |
| Short Term Investments | 70.7 | 74.4 | 75.0 | 89.0 | 80.1 | 88.3 | 92.3 | 79.2 | 64.0 | 88.6 | |
| Total Cash & ST Investments | 95.9 | 99.8 | 105.3 | 113.6 | 127.7 | 111.1 | 128.2 | 119.1 | 187.0 | 210.8 | |
| Accounts Receivable | 4.7 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.3 | 0.3 | 0.4 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -83.9 | -91.0 | |
| Other Current Assets | 0.0 | 4.2 | 3.2 | 12.0 | 4.3 | 6.2 | 6.8 | 9.5 | 19.7 | 12.7 | |
| Total Current Assets | 100.6 | 104.2 | 108.8 | 126.0 | 132.3 | 117.6 | 135.3 | 128.9 | 123.1 | 132.9 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 4.4 | 1.0 | 1.6 | 1.1 | 1.3 | 1.7 | 2.5 | 4.3 | 2.2 | 0.5 | 0.4 | 0.5 | 0.0 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 18.5 | 18.5 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.3 | 7.0 | 7.0 | 7.1 | 7.2 | 73.0 | 7.3 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 38.8 | 90.3 | 62.8 | 12.2 | 34.2 | 0.0 | 0.0 | 0.0 | 15.0 | 36.9 | 7.2 | 0.5 | 0.8 | |
| Other Long-Term Assets | 0.3 | 3.1 | 3.9 | 2.7 | 3.6 | 4.5 | 4.8 | 0.3 | 0.3 | -35.4 | -5.5 | 0.0 | 0.0 | |
| Total Long-Term Assets | 43.4 | 94.4 | 68.5 | 23.0 | 46.2 | 13.3 | 14.5 | 96.1 | 34.7 | 2.0 | 2.0 | 1.0 | 0.8 | |
| Total Assets | 161.1 | 220.3 | 197.4 | 254.6 | 251.2 | 70.8 | 98.3 | 275.6 | 243.5 | 176.1 | 94.1 | 17.4 | 14.2 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 3.2 | 0.9 | 0.9 | 1.0 | 1.1 | 1.3 | 1.5 | 1.6 | 1.8 | 1.9 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 6.9 | 6.9 | |
| Long-Term Investments | 71.3 | 81.1 | 85.2 | 90.3 | 45.7 | 38.8 | 33.2 | 62.8 | 83.9 | 91.0 | |
| Other Long-Term Assets | 0.4 | 3.0 | 3.2 | 3.1 | 3.2 | 3.4 | 4.0 | 1.7 | 2.7 | 2.9 | |
| Total Long-Term Assets | 74.9 | 84.9 | 89.3 | 94.4 | 50.1 | 43.4 | 38.7 | 68.5 | 95.3 | 102.7 | |
| Total Assets | 175.5 | 189.1 | 198.1 | 220.3 | 182.4 | 161.1 | 174.1 | 197.4 | 218.4 | 235.6 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 7.3 | 4.7 | 8.9 | 10.4 | 10.0 | 5.3 | 9.9 | 14.8 | 7.8 | 2.8 | 0.8 | 1.3 | 0.4 | |
| Short-Term Debt | 0.4 | 0.0 | 0.9 | 0.7 | 0.7 | 0.6 | 0.6 | 0.6 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 8.0 | 23.0 | 21.2 | 10.9 | 2.2 | 3.1 | 4.2 | 12.0 | 4.8 | 3.4 | 0.7 | 0.2 | 0.0 | |
| Current Liabilities | 15.7 | 31.6 | 31.0 | 21.9 | 22.9 | 14.9 | 22.4 | 27.3 | 12.8 | 6.2 | 1.6 | 1.5 | 0.4 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 9.2 | 8.8 | 6.4 | 4.7 | 7.7 | 7.3 | 10.8 | 8.9 | 9.6 | 11.4 | |
| Short-Term Debt | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 | 0.6 | 0.9 | |
| Other Current Liabilities | 9.6 | 14.1 | 11.3 | 23.0 | 7.4 | 8.4 | 9.3 | 21.2 | 17.1 | 10.5 | |
| Current Liabilities | 25.6 | 26.8 | 21.5 | 31.6 | 18.8 | 15.7 | 20.1 | 31.0 | 27.3 | 22.8 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.7 | 0.0 | 29.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 2.4 | 0.0 | 0.4 | 0.7 | 0.7 | 0.6 | 0.6 | 0.6 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 27.2 | 64.8 | 40.2 | 57.0 | 53.9 | 33.1 | 28.4 | 60.4 | 18.2 | 6.6 | 1.6 | 38.1 | 23.4 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 1.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 0.3 | 0.5 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.1 | 0.4 | 0.4 | |
| Total Liabilities | 55.4 | 57.4 | 54.0 | 64.8 | 52.2 | 27.2 | 32.1 | 40.2 | 62.0 | 55.9 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -94.1 | 0.0 | 0.0 | |
| Retained Earnings | -798.7 | -902.9 | -770.8 | -682.3 | -595.4 | -504.5 | -453.5 | -292.2 | -159.4 | -90.9 | -42.8 | -20.7 | -9.2 | |
| Comprehensive Income | -0.5 | 0.1 | -0.1 | -0.9 | -0.2 | -0.1 | -0.1 | -0.1 | -0.2 | -0.3 | -0.1 | 0.0 | 0.0 | |
| Total Common Equity | 133.8 | 155.6 | 157.2 | 197.6 | 197.3 | 37.7 | 69.9 | 215.1 | 225.3 | 169.5 | 92.5 | -20.8 | -9.2 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -948.0 | -933.4 | -917.9 | -902.9 | -806.3 | -798.7 | -787.7 | -770.8 | -769.3 | -740.0 | |
| Comprehensive Income | 0.6 | 0.5 | 0.4 | 0.1 | 0.4 | -0.5 | -0.4 | -0.1 | -1.1 | -1.1 | |
| Total Common Equity | 120.1 | 131.7 | 144.1 | 155.6 | 130.2 | 133.8 | 142.0 | 157.2 | 156.3 | 179.8 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 2.8 | 0.0 | 0.4 | 0.7 | 0.7 | 11.3 | 0.6 | 30.5 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 133.8 | 155.6 | 157.2 | 197.6 | 197.3 | 37.7 | 69.9 | 215.1 | 225.3 | 169.5 | 92.5 | -20.8 | -9.2 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 120.1 | 131.7 | 144.1 | 155.6 | 130.2 | 133.8 | 142.0 | 157.2 | 156.3 | 179.8 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -58.7 | -64.9 | -132.1 | -88.5 | -86.9 | -90.9 | -51.0 | -161.4 | -132.7 | -68.5 | -48.1 | -20.6 | -8.5 | -5.2 | |
| Depreciation & Amortization | 0.9 | 0.5 | 0.8 | 0.9 | 0.8 | 0.9 | 1.3 | 6.4 | 1.9 | 0.4 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Stock-Based Compensation | 12.2 | 12.4 | 10.9 | 20.5 | 15.0 | 14.1 | 11.2 | 16.2 | 20.1 | 14.4 | 6.1 | 0.9 | 0.0 | 0.0 | |
| Change Working Capital | -3.6 | 2.7 | 10.9 | 9.4 | -1.2 | -1.3 | -2.4 | -2.7 | 9.4 | 0.9 | 4.3 | -1.1 | 0.8 | 0.3 | |
| Change In Accounts Receivable | 0.1 | 6.1 | 0.0 | 0.2 | 0.1 | 0.1 | 4.9 | -0.8 | -4.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | -4.2 | 8.4 | -4.2 | -1.5 | 0.4 | 3.7 | -5.2 | -3.2 | 7.0 | 4.6 | 1.8 | -0.4 | 0.8 | 0.3 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.6 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | -13.4 | 2.3 | 89.4 | -20.3 | 4.7 | 24.3 | 2.4 | 0.7 | 0.6 | 0.0 | 2.8 | 0.0 | 0.0 | 0.0 | |
| Cash from Operations | -64.5 | 0.0 | 0.0 | -78.3 | -67.6 | -52.1 | -38.6 | -96.4 | -100.8 | -54.7 | -34.6 | -20.4 | -7.6 | -4.9 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -19.8 | -14.6 | -15.4 | -15.1 | -96.6 | -7.6 | -11.0 | -16.9 | -1.5 | -29.3 | |
| Depreciation & Amortization | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |
| Stock-Based Compensation | 2.9 | 0.0 | 3.1 | 3.5 | 2.9 | 0.0 | 2.9 | 2.1 | 1.3 | 5.9 | |
| Change Working Capital | 3.2 | 0.6 | 0.8 | -1.9 | -1.0 | 25.6 | -4.7 | -9.0 | 13.3 | -3.2 | |
| Change In Accounts Receivable | -0.7 | 6.7 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.1 | |
| Change In Accounts Payable | 4.0 | 0.4 | 2.4 | 1.7 | -3.0 | 0.4 | -3.5 | 1.9 | -0.4 | -2.2 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 0.4 | 2.9 | 1.5 | 0.3 | 85.6 | 3.8 | 0.2 | 2.8 | -26.3 | 2.3 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -6.8 | -24.6 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.6 | -0.1 | -0.1 | -1.3 | -0.6 | -0.3 | -0.5 | -1.6 | -1.4 | -1.2 | -0.2 | -0.5 | -0.4 | 0.0 | |
| Acquisitions | 6.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 34.2 | -67.1 | -9.6 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -52.4 | -39.7 | -120.0 | -135.7 | -164.8 | -235.2 | -47.7 | -137.4 | -161.6 | -197.3 | -148.8 | -82.5 | -5.0 | -4.5 | |
| Sales of Investment | 109.3 | 89.0 | 86.1 | 183.2 | 178.0 | 67.8 | 54.6 | 210.5 | 239.4 | 152.5 | 87.1 | 6.1 | 3.7 | 0.0 | |
| Other Investing Activities | 57.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 56.2 | 0.0 | 0.0 | 46.2 | 12.6 | -167.6 | 6.4 | 105.7 | 9.4 | -55.7 | -61.9 | -77.0 | -1.8 | -4.5 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.0 | 0.0 | 0.0 | 0.0 | -35.8 | 0.0 | 0.0 | -0.1 | -0.4 | -0.1 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 39.5 | -32.6 | |
| Investments | 25.1 | -5.2 | -19.9 | -10.0 | -70.4 | -14.3 | -35.2 | 0.0 | 0.0 | -17.2 | |
| Sales of Investment | -44.0 | 19.1 | 25.0 | 30.0 | 17.5 | 17.1 | 34.5 | 17.0 | 8.0 | 49.8 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.0 | 32.6 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 7.6 | 32.5 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -11.5 | -0.1 | -30.5 | -0.6 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 2.4 | 0.0 | -0.4 | -0.3 | 0.0 | 0.9 | 10.8 | 0.6 | 31.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 0.1 | 0.0 | 0.0 | 26.7 | 72.7 | 238.2 | 7.7 | 0.0 | 100.2 | 100.2 | 116.7 | 56.6 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 7.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -7.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | -0.1 | 0.1 | -1.7 | 10.8 | 0.2 | 28.7 | 0.2 | 0.1 | 39.9 | 10.6 | 0.0 | |
| Cash from Financing | -0.1 | 0.0 | 0.0 | 26.7 | 72.9 | 225.1 | 18.4 | -30.3 | 128.3 | 100.4 | 116.8 | 96.4 | 10.6 | 0.0 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 2.2 | 2.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.4 | 0.1 | -0.1 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -0.3 | 0.0 | 0.0 | -0.3 | 0.0 | 0.0 | 0.0 | -0.1 | 0.1 | -0.1 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -8.3 | -4.6 | -15.3 | -5.4 | 17.9 | 5.3 | -13.9 | -21.1 | 36.8 | -10.0 | 20.3 | -0.9 | 1.2 | -9.5 | |
| Closing Cash Balance | 22.8 | 20.0 | 24.6 | 39.9 | 45.3 | 27.3 | 22.1 | 35.9 | 57.0 | 20.2 | 30.2 | 9.9 | 10.8 | 9.6 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -5.3 | -0.1 | -5.0 | 5.8 | -23.1 | 24.8 | -13.0 | -4.0 | 0.8 | 7.9 | |
| Closing Cash Balance | 20.0 | 25.3 | 25.4 | 30.4 | 24.6 | 47.7 | 22.8 | 35.8 | 39.9 | 39.0 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -65.1 | -47.1 | -20.2 | -79.6 | -68.2 | -52.4 | -39.1 | -98.1 | -102.2 | -55.9 | -34.8 | -20.9 | -8.1 | -4.9 | |
| Real Free Cash Flow | -77.3 | -59.5 | -31.1 | -100.2 | -83.2 | -66.5 | -50.3 | -114.2 | -122.2 | -70.3 | -40.9 | -21.8 | -8.1 | -4.9 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -13.1 | -11.0 | -10.0 | -13.1 | -44.7 | 22.0 | -12.3 | -21.0 | -7.2 | -24.6 | |
| Real Free Cash Flow | -16.0 | -11.0 | -13.1 | -16.6 | -47.6 | 22.0 | -15.2 | -23.0 | -8.5 | -30.6 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -7 | -7.7 | 63 |
| P/S | 57.8 | 77.2 | 57.8 |
| P/B | 3.8 | 3.2 | 29.8 |
| P/FCF | -8 | -8.4 | 549.4 |
| Market cap | $0.2 | $4.0 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 1.3 % | 3 % | 0 % |
| Debt to Income | -3.5 % | -4.5 % | 0 % |
| Debt to Free cash flow | -4 % | -7684.8 % | 0 % |
| Interest expense percentage | 0 % | -0.4 % | 2.9 % |
| Current ratio | 3.9 | 11.3 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -54.1 % | -66.6 % | 0 % |
| ROA | -37 % | -50.7 % | 0 % |
| CapEx to Revenue | 228 % | 20.1 % | 0 % |
| RaD to Revenue | 0 % | 507.7 % | 0 % |
| ROEM | 122,281.3 | 94122.4 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 22.5 % | 28.3 % | 47.8 % |
| Operating margin | -973.9 % | -938.5 % | 28 % |
| Net margin | -900 % | -945 % | 19.8 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | -0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 122.6 mil | 47.8 mil |
| Employee count | 0.1 tis | 0.1 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
